{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T12:01:56Z","timestamp":1784894516285,"version":"3.55.0"},"reference-count":77,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,9,9]],"date-time":"2021-09-09T00:00:00Z","timestamp":1631145600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000196","name":"Canada Foundation for Innovation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000196","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002784","name":"Canada Excellence Research Chairs","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002784","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004117","name":"AG Leventis Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004117","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy - Methods & Clinical Development"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1016\/j.omtm.2021.09.007","type":"journal-article","created":{"date-parts":[[2021,9,14]],"date-time":"2021-09-14T02:41:13Z","timestamp":1631587273000},"page":"169-183","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"special_numbering":"C","title":["miR-223-3p and miR-24-3p as novel serum-based biomarkers for myotonic dystrophy type 1"],"prefix":"10.1016","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8882-2444","authenticated-orcid":false,"given":"Demetris","family":"Koutalianos","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrie","family":"Koutsoulidou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chrystalla","family":"Mytidou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea C.","family":"Kakouri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9350-7577","authenticated-orcid":false,"given":"Anastasis","family":"Oulas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0836-5579","authenticated-orcid":false,"given":"Marios","family":"Tomazou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8913-108X","authenticated-orcid":false,"given":"Tassos C.","family":"Kyriakides","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marianna","family":"Prokopi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4999-0231","authenticated-orcid":false,"given":"Konstantinos","family":"Kapnisis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5769-0389","authenticated-orcid":false,"given":"Nikoletta","family":"Nikolenko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chris","family":"Turner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1909-9963","authenticated-orcid":false,"given":"Anna","family":"Lusakowska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katarzyna","family":"Janiszewska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George K.","family":"Papadimas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Constantinos","family":"Papadopoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evangelia","family":"Kararizou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2470-3363","authenticated-orcid":false,"given":"George M.","family":"Spyrou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Genevi\u00e8ve","family":"Gourdon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eleni","family":"Zamba Papanicolaou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grainne","family":"Gorman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Anayiotos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanns","family":"Lochm\u00fcller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1377-211X","authenticated-orcid":false,"given":"Leonidas A.","family":"Phylactou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.omtm.2021.09.007_bib1","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1016\/S0140-6736(89)91867-9","article-title":"Postoperative complications in myotonic dystrophy","volume":"2","author":"Harper","year":"1989","journal-title":"Lancet"},{"key":"10.1016\/j.omtm.2021.09.007_bib2","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/S0361-9230(01)00656-6","article-title":"Myotonic dystrophy--a multigene disorder","volume":"56","author":"Larkin","year":"2001","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.omtm.2021.09.007_bib3","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1038\/355548a0","article-title":"Cloning of the essential myotonic dystrophy region and mapping of the putative defect","volume":"355","author":"Aslanidis","year":"1992","journal-title":"Nature"},{"key":"10.1016\/j.omtm.2021.09.007_bib4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/mus.20301","article-title":"Clinical and molecular aspects of the myotonic dystrophies: a review","volume":"32","author":"Machuca-Tzili","year":"2005","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.omtm.2021.09.007_bib5","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1002\/mus.22090","article-title":"Therapeutics development in myotonic dystrophy type 1","volume":"44","author":"Foff","year":"2011","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.omtm.2021.09.007_bib6","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1097\/WCO.0000000000000128","article-title":"Myotonic dystrophy: diagnosis, management and new therapies","volume":"27","author":"Turner","year":"2014","journal-title":"Curr. Opin. Neurol."},{"key":"10.1016\/j.omtm.2021.09.007_bib7","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1016\/S1474-4422(12)70204-1","article-title":"The myotonic dystrophies: molecular, clinical, and therapeutic challenges","volume":"11","author":"Udd","year":"2012","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.omtm.2021.09.007_bib8","first-page":"68","article-title":"The creatine kinase response to resistance exercise","volume":"14","author":"Koch","year":"2014","journal-title":"J.\u00a0Musculoskelet. Neuronal Interact."},{"key":"10.1016\/j.omtm.2021.09.007_bib9","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1001\/archneur.63.8.1149","article-title":"Laboratory abnormalities in ambulatory patients with myotonic dystrophy type 1","volume":"63","author":"Heatwole","year":"2006","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.omtm.2021.09.007_bib10","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1002\/ana.23992","article-title":"Splicing biomarkers of disease severity in myotonic dystrophy","volume":"74","author":"Nakamori","year":"2013","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.omtm.2021.09.007_bib11","doi-asserted-by":"crossref","first-page":"e0125341","DOI":"10.1371\/journal.pone.0125341","article-title":"Elevated Muscle-Specific miRNAs in Serum of Myotonic Dystrophy Patients Relate to Muscle Disease Progress","volume":"10","author":"Koutsoulidou","year":"2015","journal-title":"PLoS ONE"},{"key":"10.1016\/j.omtm.2021.09.007_bib12","doi-asserted-by":"crossref","first-page":"3285","DOI":"10.1093\/hmg\/ddx212","article-title":"Identification of exosomal muscle-specific miRNAs in serum of myotonic dystrophy patients relating to muscle disease progress","volume":"26","author":"Koutsoulidou","year":"2017","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.omtm.2021.09.007_bib13","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.nmd.2014.02.005","article-title":"Plasma microRNAs as biomarkers for myotonic dystrophy type 1","volume":"24","author":"Perfetti","year":"2014","journal-title":"Neuromuscul. Disord."},{"key":"10.1016\/j.omtm.2021.09.007_bib14","doi-asserted-by":"crossref","first-page":"38174","DOI":"10.1038\/srep38174","article-title":"Validation of plasma microRNAs as biomarkers for myotonic dystrophy type 1","volume":"6","author":"Perfetti","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.omtm.2021.09.007_bib15","doi-asserted-by":"crossref","first-page":"3939","DOI":"10.3390\/jcm9123939","article-title":"The Biomarker Potential of miRNAs in Myotonic Dystrophy Type I","volume":"9","author":"Koehorst","year":"2020","journal-title":"J.\u00a0Clin. Med."},{"key":"10.1016\/j.omtm.2021.09.007_bib16","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/j.urolonc.2009.01.027","article-title":"A robust methodology to study urine microRNA as tumor marker: microRNA-126 and microRNA-182 are related to urinary bladder cancer","volume":"28","author":"Hanke","year":"2010","journal-title":"Urol. Oncol."},{"key":"10.1016\/j.omtm.2021.09.007_bib17","doi-asserted-by":"crossref","first-page":"e3148","DOI":"10.1371\/journal.pone.0003148","article-title":"Serum microRNAs are promising novel biomarkers","volume":"3","author":"Gilad","year":"2008","journal-title":"PLoS ONE"},{"key":"10.1016\/j.omtm.2021.09.007_bib18","doi-asserted-by":"crossref","first-page":"9798","DOI":"10.1158\/0008-5472.CAN-10-1001","article-title":"Serum microRNA profiles serve as novel biomarkers for HBV infection and diagnosis of HBV-positive hepatocarcinoma","volume":"70","author":"Li","year":"2010","journal-title":"Cancer Res."},{"key":"10.1016\/j.omtm.2021.09.007_bib19","doi-asserted-by":"crossref","first-page":"4402","DOI":"10.1073\/pnas.0813371106","article-title":"Circulating microRNAs, potential biomarkers for drug-induced liver injury","volume":"106","author":"Wang","year":"2009","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.omtm.2021.09.007_bib20","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1161\/ATVBAHA.112.300741","article-title":"Characterization of levels and cellular transfer of circulating lipoprotein-bound microRNAs","volume":"33","author":"Wagner","year":"2013","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.omtm.2021.09.007_bib21","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1038\/ncb2210","article-title":"MicroRNAs are transported in plasma and delivered to recipient cells by high-density lipoproteins","volume":"13","author":"Vickers","year":"2011","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.omtm.2021.09.007_bib22","doi-asserted-by":"crossref","first-page":"e3694","DOI":"10.1371\/journal.pone.0003694","article-title":"Detection of microRNA expression in human peripheral blood microvesicles","volume":"3","author":"Hunter","year":"2008","journal-title":"PLoS ONE"},{"key":"10.1016\/j.omtm.2021.09.007_bib23","doi-asserted-by":"crossref","first-page":"2953","DOI":"10.1007\/s10072-020-04409-2","article-title":"MyomiRNAs and myostatin as physical rehabilitation biomarkers for myotonic dystrophy","volume":"41","author":"Pegoraro","year":"2020","journal-title":"Neurol. Sci."},{"key":"10.1016\/j.omtm.2021.09.007_bib24","doi-asserted-by":"crossref","first-page":"512","DOI":"10.4103\/neuroindia.NI_237_16","article-title":"Deregulation of microRNAs in blood and skeletal muscles of myotonic dystrophy type 1 patients","volume":"65","author":"Ambrose","year":"2017","journal-title":"Neurol. India"},{"key":"10.1016\/j.omtm.2021.09.007_bib25","doi-asserted-by":"crossref","first-page":"3865","DOI":"10.1093\/nar\/gkw116","article-title":"Distribution of miRNA expression across human tissues","volume":"44","author":"Ludwig","year":"2016","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.omtm.2021.09.007_bib26","doi-asserted-by":"crossref","first-page":"533","DOI":"10.2147\/DDDT.S97635","article-title":"Eteplirsen in the treatment of Duchenne muscular dystrophy","volume":"11","author":"Lim","year":"2017","journal-title":"Drug Des. Devel. Ther."},{"key":"10.1016\/j.omtm.2021.09.007_bib27","doi-asserted-by":"crossref","first-page":"2690","DOI":"10.1093\/nar\/gkn032","article-title":"Transforming growth factor-beta-regulated miR-24 promotes skeletal muscle differentiation","volume":"36","author":"Sun","year":"2008","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.omtm.2021.09.007_bib28","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/j.omtn.2018.04.005","article-title":"miR-24 and miR-122 Negatively Regulate the Transforming Growth Factor-\u03b2\/Smad Signaling Pathway in Skeletal Muscle Fibrosis","volume":"11","author":"Sun","year":"2018","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.omtm.2021.09.007_bib29","doi-asserted-by":"crossref","first-page":"2446","DOI":"10.3390\/ijms20102446","article-title":"Role of Transforming Growth Factor-\u03b2 in Skeletal Muscle Fibrosis: A Review","volume":"20","author":"Ismaeel","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.omtm.2021.09.007_bib30","doi-asserted-by":"crossref","first-page":"3335","DOI":"10.1096\/fj.08-128579","article-title":"Common micro-RNA signature in skeletal muscle damage and regeneration induced by Duchenne muscular dystrophy and acute ischemia","volume":"23","author":"Greco","year":"2009","journal-title":"FASEB J."},{"key":"10.1016\/j.omtm.2021.09.007_bib31","doi-asserted-by":"crossref","first-page":"e454","DOI":"10.1038\/emm.2017.288","article-title":"Evaluation of several methodological challenges in circulating miRNA qPCR studies in patients with head and neck cancer","volume":"50","author":"Poel","year":"2018","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.omtm.2021.09.007_bib32","doi-asserted-by":"crossref","first-page":"R90","DOI":"10.1186\/bcr2766","article-title":"Circulating microRNAs as blood-based markers for patients with primary and metastatic breast cancer","volume":"12","author":"Roth","year":"2010","journal-title":"Breast Cancer Res."},{"key":"10.1016\/j.omtm.2021.09.007_bib33","doi-asserted-by":"crossref","first-page":"2599","DOI":"10.21037\/jtd.2018.04.128","article-title":"Evaluation of the performance of serum miRNAs as normalizers in microRNA studies focused on cardiovascular disease","volume":"10","author":"Wang","year":"2018","journal-title":"J.\u00a0Thorac. Dis."},{"key":"10.1016\/j.omtm.2021.09.007_bib34","doi-asserted-by":"crossref","first-page":"7223","DOI":"10.1093\/nar\/gkr254","article-title":"Characterization of extracellular circulating microRNA","volume":"39","author":"Turchinovich","year":"2011","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.omtm.2021.09.007_bib35","doi-asserted-by":"crossref","first-page":"5003","DOI":"10.1073\/pnas.1019055108","article-title":"Argonaute2 complexes carry a population of circulating microRNAs independent of vesicles in human plasma","volume":"108","author":"Arroyo","year":"2011","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.omtm.2021.09.007_bib36","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.4161\/rna.21083","article-title":"Distinct AGO1 and AGO2 associated miRNA profiles in human cells and blood plasma","volume":"9","author":"Turchinovich","year":"2012","journal-title":"RNA Biol."},{"key":"10.1016\/j.omtm.2021.09.007_bib37","doi-asserted-by":"crossref","first-page":"8935","DOI":"10.3390\/ijms21238935","article-title":"From Mice to Humans: An Overview of the Potentials and Limitations of Current Transgenic Mouse Models of Major Muscular Dystrophies and Congenital Myopathies","volume":"21","author":"Sztretye","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.omtm.2021.09.007_bib38","doi-asserted-by":"crossref","first-page":"519","DOI":"10.3389\/fneur.2018.00519","article-title":"Of Mice and Men: Advances in the Understanding of Neuromuscular Aspects of Myotonic Dystrophy","volume":"9","author":"Braz","year":"2018","journal-title":"Front. Neurol."},{"key":"10.1016\/j.omtm.2021.09.007_bib39","doi-asserted-by":"crossref","first-page":"e1003043","DOI":"10.1371\/journal.pgen.1003043","article-title":"Molecular, physiological, and motor performance defects in DMSXL mice carrying >1,000 CTG repeats from the human DM1 locus","volume":"8","author":"Huguet","year":"2012","journal-title":"PLoS Genet."},{"key":"10.1016\/j.omtm.2021.09.007_bib40","doi-asserted-by":"crossref","first-page":"e52","DOI":"10.1371\/journal.pgen.0030052","article-title":"CTG trinucleotide repeat \u201cbig jumps\u201d: large expansions, small mice","volume":"3","author":"Gomes-Pereira","year":"2007","journal-title":"PLoS Genet."},{"key":"10.1016\/j.omtm.2021.09.007_bib41","doi-asserted-by":"crossref","first-page":"eaau6977","DOI":"10.1126\/science.aau6977","article-title":"The biology, function, and biomedical applications of exosomes","volume":"367","author":"Kalluri","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.omtm.2021.09.007_bib42","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1016\/0002-8703(73)90338-4","article-title":"Electrophysiological and histological abnormalities of the heart in myotonic dystrophy","volume":"86","author":"Uemura","year":"1973","journal-title":"Am. Heart J."},{"key":"10.1016\/j.omtm.2021.09.007_bib43","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1136\/heart.88.6.665","article-title":"Myotonic dystrophy and the heart","volume":"88","author":"Pelargonio","year":"2002","journal-title":"Heart"},{"key":"10.1016\/j.omtm.2021.09.007_bib44","doi-asserted-by":"crossref","first-page":"2150","DOI":"10.1111\/j.1582-4934.2012.01523.x","article-title":"MicroRNA-24 regulates cardiac fibrosis after myocardial infarction","volume":"16","author":"Wang","year":"2012","journal-title":"J.\u00a0Cell. Mol. Med."},{"key":"10.1016\/j.omtm.2021.09.007_bib45","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1159\/000489185","article-title":"MicroRNA-223 Regulates Cardiac Fibrosis After Myocardial Infarction by Targeting RASA1","volume":"46","author":"Liu","year":"2018","journal-title":"Cell. Physiol. Biochem."},{"key":"10.1016\/j.omtm.2021.09.007_bib46","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1111\/jcmm.12393","article-title":"Cardiomyocyte-specific role of miR-24 in promoting cell survival","volume":"19","author":"Guo","year":"2015","journal-title":"J.\u00a0Cell. Mol. Med."},{"key":"10.1016\/j.omtm.2021.09.007_bib47","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1159\/000455816","article-title":"Hydrogen Sulfide Protects Cardiomyocytes against Apoptosis in Ischemia\/Reperfusion through MiR-1-Regulated Histone Deacetylase 4 Pathway","volume":"41","author":"Kang","year":"2017","journal-title":"Cell. Physiol. Biochem."},{"key":"10.1016\/j.omtm.2021.09.007_bib48","first-page":"916","article-title":"MicroRNA-206 Protects against Myocardial Ischaemia-Reperfusion Injury in Rats by Targeting Gadd45\u03b2","volume":"40","author":"Zhai","year":"2017","journal-title":"Mol. Cells"},{"issue":"D1","key":"10.1016\/j.omtm.2021.09.007_bib49","doi-asserted-by":"crossref","first-page":"D419","DOI":"10.1093\/nar\/gky1038","article-title":"PANTHER version 14: more genomes, a new PANTHER GO-slim and improvements in enrichment analysis tools","volume":"47","author":"Mi","year":"2019","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.omtm.2021.09.007_bib50","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1038\/s41596-019-0128-8","article-title":"Protocol Update for large-scale genome and gene function analysis with the PANTHER classification system (v.14.0)","volume":"14","author":"Mi","year":"2019","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.omtm.2021.09.007_bib51","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.omtm.2020.05.017","article-title":"Circulating Biomarkers in Muscular Dystrophies: Disease and Therapy Monitoring","volume":"18","author":"Koutsoulidou","year":"2020","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.omtm.2021.09.007_bib52","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1083\/jcb.201211138","article-title":"Extracellular vesicles: exosomes, microvesicles, and friends","volume":"200","author":"Raposo","year":"2013","journal-title":"J.\u00a0Cell Biol."},{"key":"10.1016\/j.omtm.2021.09.007_bib53","doi-asserted-by":"crossref","first-page":"27066","DOI":"10.3402\/jev.v4.27066","article-title":"Biological properties of extracellular vesicles and their physiological functions","volume":"4","author":"Y\u00e1\u00f1ez-M\u00f3","year":"2015","journal-title":"J.\u00a0Extracell. Vesicles"},{"key":"10.1016\/j.omtm.2021.09.007_bib54","doi-asserted-by":"crossref","first-page":"5473","DOI":"10.1158\/1078-0432.CCR-09-0736","article-title":"Salivary microRNA: discovery, characterization, and clinical utility for oral cancer detection","volume":"15","author":"Park","year":"2009","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.omtm.2021.09.007_bib55","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/s00414-009-0402-3","article-title":"MicroRNA markers for forensic body fluid identification obtained from microarray screening and quantitative RT-PCR confirmation","volume":"124","author":"Zubakov","year":"2010","journal-title":"Int. J. Legal Med."},{"key":"10.1016\/j.omtm.2021.09.007_bib56","doi-asserted-by":"crossref","first-page":"4569","DOI":"10.1007\/s00018-019-03290-3","article-title":"MicroRNA-24-3p regulates neuronal differentiation by controlling hippocalcin expression","volume":"76","author":"Kang","year":"2019","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.omtm.2021.09.007_bib57","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1186\/s13041-019-0471-2","article-title":"Identification of plasma microRNA expression changes in multiple system atrophy and Parkinson\u2019s disease","volume":"12","author":"Uwatoko","year":"2019","journal-title":"Mol. Brain"},{"key":"10.1016\/j.omtm.2021.09.007_bib58","doi-asserted-by":"crossref","first-page":"18962","DOI":"10.1073\/pnas.1121288109","article-title":"MicroRNA-223 is neuroprotective by targeting glutamate receptors","volume":"109","author":"Harraz","year":"2012","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.omtm.2021.09.007_bib59","doi-asserted-by":"crossref","first-page":"2979","DOI":"10.1093\/brain\/awz245","article-title":"MicroRNA-223 protects neurons from degeneration in experimental autoimmune encephalomyelitis","volume":"142","author":"Morquette","year":"2019","journal-title":"Brain"},{"key":"10.1016\/j.omtm.2021.09.007_bib60","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1002\/jnr.21377","article-title":"Myotonic dystrophy 1 in the nervous system: from the clinic to molecular mechanisms","volume":"86","author":"de Le\u00f3n","year":"2008","journal-title":"J.\u00a0Neurosci. Res."},{"key":"10.1016\/j.omtm.2021.09.007_bib61","doi-asserted-by":"crossref","first-page":"2114","DOI":"10.1093\/bioinformatics\/btu170","article-title":"Trimmomatic: a flexible trimmer for Illumina sequence data","volume":"30","author":"Bolger","year":"2014","journal-title":"Bioinformatics"},{"key":"10.1016\/j.omtm.2021.09.007_bib62","doi-asserted-by":"crossref","first-page":"R25","DOI":"10.1186\/gb-2009-10-3-r25","article-title":"Ultrafast and memory-efficient alignment of short DNA sequences to the human genome","volume":"10","author":"Langmead","year":"2009","journal-title":"Genome Biol."},{"key":"10.1016\/j.omtm.2021.09.007_bib63","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1093\/bioinformatics\/btu638","article-title":"HTSeq--a Python framework to work with high-throughput sequencing data","volume":"31","author":"Anders","year":"2015","journal-title":"Bioinformatics"},{"key":"10.1016\/j.omtm.2021.09.007_bib64","article-title":"miRBase: microRNA sequences and annotation","volume":"Chapter 12","author":"Griffiths-Jones","year":"2010","journal-title":"Curr. Protoc. Bioinformatics"},{"key":"10.1016\/j.omtm.2021.09.007_bib65","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1093\/bioinformatics\/btp616","article-title":"edgeR: a Bioconductor package for differential expression analysis of digital gene expression data","volume":"26","author":"Robinson","year":"2010","journal-title":"Bioinformatics"},{"key":"10.1016\/j.omtm.2021.09.007_bib66","doi-asserted-by":"crossref","first-page":"R25","DOI":"10.1186\/gb-2010-11-3-r25","article-title":"A scaling normalization method for differential expression analysis of RNA-seq data","volume":"11","author":"Robinson","year":"2010","journal-title":"Genome Biol."},{"key":"10.1016\/j.omtm.2021.09.007_bib67","doi-asserted-by":"crossref","DOI":"10.1515\/1544-6115.1826","article-title":"Detecting differential expression in RNA-sequence data using quasi-likelihood with shrunken dispersion estimates","volume":"11","author":"Lund","year":"2012","journal-title":"Stat. Appl. Genet. Mol. Biol."},{"key":"10.1016\/j.omtm.2021.09.007_bib68","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1186\/1471-2105-7-85","article-title":"Statistical analysis of real-time PCR data","volume":"7","author":"Yuan","year":"2006","journal-title":"BMC Bioinformatics"},{"key":"10.1016\/j.omtm.2021.09.007_bib69","doi-asserted-by":"crossref","first-page":"2498","DOI":"10.1101\/gr.1239303","article-title":"Cytoscape: a software environment for integrated models of biomolecular interaction networks","volume":"13","author":"Shannon","year":"2003","journal-title":"Genome Res."},{"key":"10.1016\/j.omtm.2021.09.007_bib70","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1093\/bioinformatics\/btp101","article-title":"ClueGO: a Cytoscape plug-in to decipher functionally grouped gene ontology and pathway annotation networks","volume":"25","author":"Bindea","year":"2009","journal-title":"Bioinformatics"},{"key":"10.1016\/j.omtm.2021.09.007_bib71","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1093\/bioinformatics\/btt019","article-title":"CluePedia Cytoscape plugin: pathway insights using integrated experimental and in\u00a0silico data","volume":"29","author":"Bindea","year":"2013","journal-title":"Bioinformatics"},{"key":"10.1016\/j.omtm.2021.09.007_bib72","doi-asserted-by":"crossref","first-page":"D146","DOI":"10.1093\/nar\/gku1104","article-title":"miRDB: an online resource for microRNA target prediction and functional annotations","volume":"43","author":"Wong","year":"2015","journal-title":"Nucleic Acids Res."},{"issue":"D1","key":"10.1016\/j.omtm.2021.09.007_bib73","doi-asserted-by":"crossref","first-page":"D296","DOI":"10.1093\/nar\/gkx1067","article-title":"miRTarBase update 2018: a resource for experimentally validated microRNA-target interactions","volume":"46","author":"Chou","year":"2018","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.omtm.2021.09.007_bib74","doi-asserted-by":"crossref","first-page":"D105","DOI":"10.1093\/nar\/gkn851","article-title":"miRecords: an integrated resource for microRNA-target interactions","volume":"37","author":"Xiao","year":"2009","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.omtm.2021.09.007_bib75","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1002\/wics.147","article-title":"ggplot2","volume":"3","author":"Wickham","year":"2011","journal-title":"Wiley Interdiscip. Rev. Comput. Stat."},{"key":"10.1016\/j.omtm.2021.09.007_bib76","doi-asserted-by":"crossref","first-page":"10212","DOI":"10.1074\/jbc.RA119.012263","article-title":"MicroRNA-223-3p promotes skeletal muscle regeneration by regulating inflammation in mice","volume":"295","author":"Cheng","year":"2020","journal-title":"J Biol Chem"},{"key":"10.1016\/j.omtm.2021.09.007_bib77","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1016\/j.bbadis.2014.03.005","article-title":"miR-223: An inflammatory oncomiR enters the cardiovascular field","volume":"1842","author":"Ta\u00efbi","year":"2014","journal-title":"Biochim Biophys Acta"}],"container-title":["Molecular Therapy - Methods & Clinical Development"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2329050121001443?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2329050121001443?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T09:28:30Z","timestamp":1762421310000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2329050121001443"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12]]},"references-count":77,"alternative-id":["S2329050121001443"],"URL":"https:\/\/doi.org\/10.1016\/j.omtm.2021.09.007","relation":{},"ISSN":["2329-0501"],"issn-type":[{"value":"2329-0501","type":"print"}],"subject":[],"published":{"date-parts":[[2021,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"miR-223-3p and miR-24-3p as novel serum-based biomarkers for myotonic dystrophy type 1","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy - Methods & Clinical Development","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.omtm.2021.09.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Author(s).","name":"copyright","label":"Copyright"}]}}